Skip to main content
NCBI home page
Canadian Journal of Veterinary Research logoLink to Canadian Journal of Veterinary Research
. 1987 Jan;51(1):60–65.

Suppression of cortisol responses to exogenous adrenocorticotrophic hormone, and the occurrence of side effects attributable to glucocorticoid excess, in cats during therapy with megestrol acetate and prednisolone.

D J Middleton, A D Watson, C J Howe, I D Caterson
PMCID: PMC1255275  PMID: 3032391

Abstract

The major purpose of this investigation was to determine the effect of prednisolone and megestrol acetate in cats on the adrenal cortisol response to exogenous adrenocorticotrophic hormone during drug administration at dose rates employed for management of some inflammatory feline dermatoses. Prednisolone (at least 2 mg/kg/day) and megestrol acetate (5 mg/cat/day) were each administered orally to seven cats from days 1 to 16. Three additional cats received no therapy. Basal and stimulated cortisol concentrations, food and water intake, hematology, blood biochemistry, urinalyses, and hepatic and cutaneous histology were studied in all cats before, during, and two weeks following the end of treatment. Cats given prednisolone or megestrol acetate had significant suppression of stimulated cortisol levels on day 8. This change was more marked on day 15, when the suppression in cats given megestrol acetate was also significantly more severe than in those receiving prednisolone. Recovery of adrenal reserve was considered present on day 30 in six of seven cats given prednisolone, but in only three of seven receiving megestrol acetate. Eosinopenia, glycosuria and hepatocyte swelling from glycogen deposition were occasionally recorded in treated cats of both groups, providing additional circumstantial evidence for glucocorticoid activity of megestrol acetate in cats. It is advised that abrupt withdrawal of prednisolone or megestrol acetate therapy be avoided in this species to reduce the chance of precipitating clinical signs of hypoadrenocorticism, even after treatment for as little as one week.

Full text

PDF
60

Images in this article

63Fig. 2.
on p.63

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altszuler N., Morrison A., Gottlieb B., Bjerknes C., Rathgeb I., Steele R. Alteration by fasting of the effects of methylprednisolone on carbohydrate metabolism in the normal dog. Metabolism. 1974 Apr;23(4):369–374. doi: 10.1016/0026-0495(74)90055-9. [DOI] [PubMed] [Google Scholar]
  2. Badylak S. F., Van Vleet J. F. Sequential morphologic and clinicopathologic alterations in dogs with experimentally induced glucocorticoid hepatopathy. Am J Vet Res. 1981 Aug;42(8):1310–1318. [PubMed] [Google Scholar]
  3. Baxter J. D. Glucocorticoid hormone action. Pharmacol Ther B. 1976;2(3):605–669. doi: 10.1016/0306-039x(76)90010-6. [DOI] [PubMed] [Google Scholar]
  4. Chastain C. B., Graham C. L. Adrenocortical suppression in dogs on daily and alternate-day prednisone administration. Am J Vet Res. 1979 Jul;40(7):936–941. [PubMed] [Google Scholar]
  5. Chastain C. B., Graham C. L., Nichols C. E. Adrenocortical suppression in cats given megestrol acetate. Am J Vet Res. 1981 Dec;42(12):2029–2035. [PubMed] [Google Scholar]
  6. Christoffersen P., Poulsen H., Skeie E. Focal liver cell necroses accompanied by infiltration of granulocytes arising during operation. Acta Hepatosplenol. 1970 Jul-Aug;17(4):240–245. [PubMed] [Google Scholar]
  7. Cunningham S. K., Moore A., McKenna T. J. Normal cortisol response to corticotropin in patients with secondary adrenal failure. Arch Intern Med. 1983 Dec;143(12):2276–2279. [PubMed] [Google Scholar]
  8. FIELDER F. G., HOFF E. J., THOMAS G. B., TOLKSDORF S., PERLMAN P. L., CRONIN M. T. A study of the subacute toxicity of prednisolone, methylprednisolone, and triamcinolone in dogs. Toxicology. 1959 May;1(3):305–314. doi: 10.1016/0041-008x(59)90115-2. [DOI] [PubMed] [Google Scholar]
  9. HOLUB S. A., KATZ F. H., JAILER J. W. Inhibition by 6-methyl-17-acetoxy-progesterone of ACTH synthesis and release in the rat. Endocrinology. 1961 Jan;68:173–177. doi: 10.1210/endo-68-1-173. [DOI] [PubMed] [Google Scholar]
  10. Jasper D. E., Jain N. C. The influence of adrenocorticotropic hormone and prednisolone upon marrow and circulating leukocytes in the dog. Am J Vet Res. 1965 Jul;26(113):844–850. [PubMed] [Google Scholar]
  11. Johnston S. D., Mather E. C. Feline plasma cortisol (hydrocortisone) measured by radioimmunoassay. Am J Vet Res. 1979 Feb;40(2):190–192. [PubMed] [Google Scholar]
  12. Kemppainen R. J., Thompson F. N., Lorenz M. D. Use of a low dose synthetic ACTH challenge test in normal and prednisone-treated dogs. Res Vet Sci. 1983 Sep;35(2):240–242. [PubMed] [Google Scholar]
  13. Meijer J. C., Lubberink A. A., Gruys E. Cushing's syndrome due to adrenocortical adenoma in a cat. Tijdschr Diergeneeskd. 1978 Oct 15;103(20):1048–1051. [PubMed] [Google Scholar]
  14. Middleton D. J., Watson A. D. Glucose intolerance in cats given short-term therapies of prednisolone and megestrol acetate. Am J Vet Res. 1985 Dec;46(12):2623–2625. [PubMed] [Google Scholar]
  15. Reimers T. J., Cowan R. G., Davidson H. P., Colby E. D. Validation of radioimmunoassay for triiodothyronine, thyroxine, and hydrocortisone (cortisol) in canine, feline, and equine sera. Am J Vet Res. 1981 Nov;42(11):2016–2021. [PubMed] [Google Scholar]
  16. Rogers W. A., Ruebner B. H. A retrospective study of probable glucocorticoid-induced hepatopathy in dogs. J Am Vet Med Assoc. 1977 Mar 15;170(6):603–606. [PubMed] [Google Scholar]
  17. Scott D. W., Kirk R. W., Bentinck-Smith J. Some effects of short-term methylprednisolone therapy in normal cats. Cornell Vet. 1979 Jan;69(1):104–115. [PubMed] [Google Scholar]
  18. Swift G. A., Brown R. H. Surgical treatment of Cushing's syndrome in the cat. Vet Rec. 1976 Nov 6;99(19):374–375. doi: 10.1136/vr.99.19.374. [DOI] [PubMed] [Google Scholar]
  19. Weikel J. H., Jr, Nelson L. W., Reno F. E. A four-year evaluation of the chronic toxicity of megestrol acetate in dogs. Toxicol Appl Pharmacol. 1975 Sep;33(3):414–426. doi: 10.1016/0041-008x(75)90068-x. [DOI] [PubMed] [Google Scholar]
  20. Wiener J., Loud A. V., Kimberg D. V., Spiro D. A quantitative description of cortisone-induced alterations in the ultrastructure of rat liver parenchmal cells. J Cell Biol. 1968 Apr;37(1):47–61. doi: 10.1083/jcb.37.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Journal of Veterinary Research are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES